Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASPIRED: Ketamine and CRP for Suicidality in the ED
NCT07868913Phase 2Recruiting
- Sponsor
- UT Health San Antonio
- Start
- Sep 2026
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in suicidal ideation, sponsored by UT Health San Antonio. Started Sep 2026; status: recruiting.
02
Drugs
ketamine
03
Conditions
suicidal ideation
Beyond the preview
Go deeper on NCT07868913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07868913.